MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
29.24%
Quick Ratio
29.24%
Cash Ratio
26.66%
Debt to Asset Ratio
216.07%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Goodwill (provisional)
    • Intangible assets, net (provisio...
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Warrant liabilities
    • Others
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
6,713
7,797
7,184
2,910
Accounts receivable, net
181
161
239
-
Prepaid expense and other current assets
467
934
1,437
1,680
Subscription receivable
-
-
3,087
-
Total current assets
7,361
8,892
11,947
4,590
Investments
399
397
-
-
Ppe
-
93
93
-
Nrx Segment
-
23
23
-
Dura Segment
-
7
1
-
Ppe
306
-
-
-
Less accumulated depreciation
47
30
24
-
Furniture and equipment, net
259
63
69
-
Right-of-use assets, net-Nonrelated Party
743
414
107
-
Right-of-use assets, net-Related Party
193
219
243
-
Intangible assets, net (provisional)
879
925
1,777
-
Goodwill (provisional)
1,793
1,793
610
-
Other assets
276
253
243
248
Total assets
11,903
12,956
14,996
4,838
Convertible note payable and accrued interest, current
-
0
9,909
9,854
Accounts payable
4,399
4,270
4,257
3,630
Accrued and other current liabilities
11,280
11,337
9,875
9,974
Insurance loan payable
-
0
152
378
Accrued clinical site costs
340
351
351
351
Warrant liabilities
8,766
12,304
15,860
16,266
Lease liability, short term-Nonrelated Party
283
211
87
-
Lease liability, short term-Related Party
108
105
102
-
Total current liabilities
25,176
28,578
40,593
40,453
Convertible note payable and accrued interest, long term
-
0
0
0
Lease liability, noncurrent-Nonrelated Party
455
199
15
-
Lease liability, noncurrent-Related Party
88
116
143
-
Total liabilities
25,719
28,893
40,751
40,453
Preferred stock-Nondesignated Preferred Stock
0
0
0
0
Preferred stock-Series AConvertible Preferred Stock
0
0
0
0
Common stock, 0.001 par value, 500,000,000 shares authorized 33,471,315 and 31,734,333 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
33
32
28
19
Additional paid-in capital
294,476
290,926
281,473
265,732
Accumulated deficit
-308,325
-306,895
-307,256
-301,366
Total stockholders deficit
-13,816
-15,937
-25,755
-35,615
Total liabilities and stockholders' deficit
11,903
12,956
14,996
4,838
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$6,713K Prepaid expense andother current assets$467K Accounts receivable, net$181K Ppe$306K Total current assets$7,361K Goodwill (provisional)$1,793K Intangible assets, net(provisional)$879K Right-of-use assets,net-Nonrelated Party$743K Investments$399K Other assets$276K Furniture and equipment,net$259K Right-of-use assets,net-Related Party$193K Less accumulateddepreciation$47K Total assets$11,903K Accumulated deficit-$308,325K Total liabilities andstockholders' deficit$11,903K Total stockholdersdeficit-$13,816K Additional paid-in capital$294,476K Common stock, 0.001 parvalue, 500,000,000...$33K Total liabilities$25,719K Total currentliabilities$25,176K Lease liability,noncurrent-Nonrelated Party$455K Lease liability,noncurrent-Related Party$88K Accrued and othercurrent liabilities$11,280K Warrant liabilities$8,766K Accounts payable$4,399K Accrued clinical sitecosts$340K Lease liability,short...$283K Lease liability,short term-Related...$108K

NRX Pharmaceuticals, Inc. (NRXPW)

NRX Pharmaceuticals, Inc. (NRXPW)